Analysis of anesthetic-related morbidity in human recipients of renal homografts. by Aldrete, JA et al.
• 
cSla AND • 
na cSla 
•••.• CURRENT RESEARCHES 
Analysis of Anesthetic-Related Morbidity in Human 
Recipients of Renal Homografts 
1(111flllli (1/ tlte lllteflllltklHlll,Allestitesill /{eSCIlfclt S(lcietg 
Volume 50, No.3 May-June, 1971 
321 
Analysis of Anesthetic-Related Morbidity 
in Human Recipients of Renal Homografts 
J. ANTONIO ALDRETE, M.D., M.S. 
WALTER DANIEL, M.D. 
JOHN W. O'HIGGINS, M.B. 
JOHN HOMATAS, M.D. 
THOMAS E. STARZL, M.D., Ph.D. 
Denver, Colorado* 
K IDNEY transplantation in humans has in 
the last decade changed from a prom-
ising clinical investigation to a practical 
reality. A common denominator in the pre-
operative condition of the recipient is ter-
minal renal failure, which often is exacer-
bated by concomitant diseases. The conse-
quent problems encountered during the an-
esthetic management of patients undergoing 
kidney homograft operations have been doc-
umented by many authors.1-14 
The early reports~I9I14 from our center 
were based on experience with the first 50 
patients in our series. Since then, the total 
number of renal transplantations at the 
University of Colorado Medical Center has 
increased to 285."1" In the present communi-
cation, the intraoperative management of 
260 of these patients is described, as well as 
the anesthetic complications encountered. 
CLINICAL MATERIAL 
Sex.-Two hundred thirty-nine patients, 
of whom 80 (31 percent) were females and 
180 (69 percent) males, received 260 kid-
neys. Eighteen patients had a second and 
3 patients had a third transplant. 
Origin of Kidneys. - There were 254 
homografts and 6 heterografts. Of the for-
mer, 2 were from identical twins, 221 from 
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living donors (usually relatives), and 31 
from cadaveric donors. 
Preoperative Physical Status.-Recipient 
physical condition, evaluated at the time of 
transplant, showed no patients in A.S.A. 
class I, 20 in class II (7.7 percent), 150 in 
class III (57.7 percent), and 90 in class IV 
(34.6 percent) . 
Age.-Most of the recipients were in the 
second, third, and fourth decades. The old-
est was 57 and the youngest was 3 years of 
age (average 27.2 years). 
Preanesthetic M ed ica t ion .-Forty-four 
patients, all class IV, received no preanes-
thetic medication. The others received anti-
cholinergic drugs, with or without narcotics, 
phenothiazines, and barbiturates. 
Duration of Anesthesia. - The longest 
surgical procedure lasted 780 minutes and 
the shortest was 150 (average 329 minutes). 
In slightly more than three-fourths of the 
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cases, splenectomy and bilateral nephrec-
tomy were performed at the same time as 
the renal transplant. For this reason, the 
period of anesthesia was not a reflection of 
the time required for homograft insertion. 
Anesthetic Technics.-A typical scheme 
of the anesthetic management of 1 of these 
patients is shown in figure 1. Anesthesia was 
intravenously induced by ultrashort-acting 
barbiturates in 197 patients and by inhala-
tion in 25 cases. These 222 patients (85.4 
percent) received inhalation anesthetic 
agents for maintenance. In addition, sub-
arachnoid block with tetracaine and epi-
nephrine was given to 14 recipients (5.4 
percent), but had to be supplemented by 
inhalation agents either because of discom-
fort, lack of anesthesia, or protracted sur-
gical procedures. For similar reasons, epi-
dural blocks administered to 22 patients 
(8.4 percent) were unsatisfactory and gen-
eral anesthesia was eventually administered 
to them. Only in one instance each were 
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FIG. 1. Typical intraoperative management of a kidney transplant recipient, as shown in a scheme 
of an anesthetic record, demonstrating the changes of art.erial pressure, heart rate, and temperature during 
operation. Anesthetic agents, muscle relaxants, and other data are shown at corresponding times of admin-
istration. Notice initial fall of blood pressure after induction of anesthesia. 
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epidural (OA percent) and spinal (OA per-
cent) blocks solely adequate for the whole 
operation. 
The technic and anesthetic agents (table 
1) were selected by the staff anesthesiolo-
gist and resident participating in each case, 
according to the individual patient, the con-
templated operative procedure, and the 
judgment of the anesthesiologists involved. 
Muscle Relaxant Drugs.-Muscle relax-
ants were used during 239 of the 260 trans-
plants. Succinylcholine alone was used to 
obtain muscle relaxation in 33 instances 
( 13.8 percent) ; in 24 of these, a single dose 
was given to facilitate endotracheal intuba-
tion; in the other 9 cases, repeated injections 
were given. An initial dose of succinylcho-
line was followed by the subsequent admin-
istration of d-tubocurarine in 89 patients 
(37.2 percent) and of gallamine triethiod-
ide in 8 cases (3.3 percent), 102 patients 
(42.7 percent) receiving d-tubocurarine ex-
TABLE 1 
Main Inhalation Anesthetic Agents Used 
in the Management of Renal 
Transplant Recipients 
Number Percent 
- ----- -----
Halothane 142 55.0 
Fluroxene 87 33.6 
Methoxyflurane 23 9.0 
Nitrous oxide +narcotic + 
relaxant 4 1.6 
Cyclopropane 2 0.8 
Total 258 100.0 
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clusively and 7 patients (3 percent) receiv-
ing gallamine alone. 
Blood and Fluid Replacement.-During 
the surgical procedure, an effort was made 
to limit fluid intake to the estimated daily 
requirement to 10 ml./kg./24 hr. However, 
these considerations were individualized. 
The average amount of fluids actually ad-
ministered before the arrival of the homo-
graft was 472 ml. of either 5 percent dextrose 
in lactated Ringer's solution or acetate, or 
2.5 percent dextrose in 0.25 percent saline 
solution. After revascularization of the 
homograft, fluids were given in amounts ap-
proximately equal to the urine produced. 
Recipient patients came to the operating 
rooms with hematocrit values ranging be-
tween 15 and 38 percent, averaging 24 per-
cent. The average estimated blood loss from 
the transplant was about 175 ml. The total 
blood loss varied mainly according to the 
extent and number of other surgical proced-
ures performed concomitantly. When bilat-
eral nephrectomy and splenectomy were si-
multaneously performed, an extra blood loss 
of about 625 ml. occurred. After the lapa-
rotomy and groin incisions had been closed, 
the anesthesiology team noted on two occa-
sions that blood transfusions were needed to 
maintain the arterial blood pressure, des-
pite replacement of adequate urine output; 
the peritoneal cavity was re-explored and 
bleeding, from the splenic and renal vascu-
lar pedicles, was found. 
ANESTHETIC COMPLICATIONS 
Arterial Hypotension.-Most patients 
were hypertensive before premedication or 
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anesthesia; subsequently, falls of systolic 
blood pressure exceeding 25 percent of the 
preanesthetic reading were observed in 145 
recipients (55.7 percent). Twenty-eight 
(19.3 percent) of these episodes occurred 
during or within 10 minutes of induction 
102 (70.3 percent) were within the 1st hou; 
after induction, and 15 (10.3 percent) were 
after the 1st hour. 
It may be significant that the peak inci-
dence of hypotension during the 1st hour of 
anesthesia usually corresponded to the time 
when the diseased kidneys, as well as the 
spleen, were being excised. These falls in 
blood pressure did not have the same sig-
nificance as in ordinary surgical cases be-
cause the original levels were so often ab-
normally high. When hypotension was de-
fined as a systolic blood pressure of 90 mm. 
Hg or below, the incidence of the complica-
tio.n was only 21 (8 percent); 14 of these 
epIsodes occurred during or within 10 min-
utes of induction and the other 7 were 
afterward. 
Cardiac Arrhythmias.-These were diag-
nosed by esophageal stethoscope and/or by 
electrocardiogram monitoring. Seven pa-
tients, 5 male and 2 female, had dangerous 
arrhythmias. In 6 instances, halothane was 
the main anesthetic agent, cyclopropane be-
ing used in the other case_ Asystole oc-
curred in 2 of these patients, 1 hour and 7 
hours, respectively, after induction. Pre-
operative serum potassium in both these 
recipients was above 6 mEq./L. The cardiac 
arrests were treated with 100 percent oxy-
gen, closed cardiac massage, insulin and 
glucose infusion, and the administration of 
bicarbonate. A spontaneous heart beat was 
restored, and in both cases a subsequent 
diuresis helped to correct the electrolyte 
imbalance in the following hours. 
In another recipient in whom preoperative 
serum potassium was below 2.5 mEq./L., 
bigeminal rhythm was observed. Premature 
ventricular beats were noted at various 
TABLE 2 
Incidence of Cardiac Arrhythmias 
Sex 
Males 
Females 
Anesthetic agent 
Cyclopropane 
Halothane 
Type of arrhythmias 
Cardiac arrest 
Bigeminy 
Premature ventricular beats 
5 
2 
1 
6 
2 
1 
4 
t~mes during the procedure in 4 other pa-
tients who had postdialysis and preoperative 
plasma potassium concentrations of between 
5 and 6 mEq./L. (table 2). 
Hiccups. - This complication occurred 
during the surgical procedure in 14 patients 
(5.4 percent), 11 male and 3 female. The 
main anesthetic agent being used was halo-
thane in 8 cases, fluroxene in 3, methoxy-
flurane in 2, and nitrous oxide in the other. 
The muscle relaxant drug in 12 of these 14 
cases was d-tubocurarine, the other 2 re-
ceiving gallamine or succinylcholine. 
Prolonged Muscle Paralysis.-Ten renal 
recipients received nondepolarizing relax-
ants and at the end of the surgical proced-
ure failed to regain muscle strength and ade-
quate respiratory function despite adequate 
doses of anticholinesterase-type drugs. This 
c?mplication was observed in 3 of 15 pa-
tients (20 percent) who received gallamine 
(with or without succinylcholine) and in 7 
of 191 recipients (3.6 percent) to whom 
d-tubocurarine was given with or without 
the . previous administration of succinyl-
cholme (table 3). The preanesthetic serum 
potassium concentrations in these 10 recipi-
ents ranged from abnormally high through 
normal to pathologically low. 
TABLE 3 
Incidence of Prolonged Muscle Paralysis 
Muscle relaxant drug Number of Number of Percent Significance 
patients prolonged 
weakness 
Gallamine 15 3 20 ( 
d-Tubocurarine 191 7 3.6 \ p= <0.01 
Total 206 10 -U-( of all cases) 
(all males) 
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Changes in Body Temperature.-In 89 
cases, intermittent or continuous temper-
ature determinations were obtained; such 
measurements have been made more system-
atically since one of the cardiac arrests 
alluded to earlier. In this patient, the serum 
potassium was 7.S mEq./L. when asystole 
occurred. At the same time, the esophageal 
temperature was noted to be 39.8° C. 
(103+° F.). Moderate intraoperative hy-
perpyrexia has been frequently observed in 
recent cases in which it has been specifically 
looked for by continuous monitoring. It may 
be that the use of intramuscular antilymph-
ocyte globulin, which is often pyrogenic,l;), 1 G 
contributes to the incidence of this compli-
cation.17 
Liver Injury.-Abnormalities in hepatic 
function have frequently been detected in 
the post-transplantation period.1 8 It has not 
been possible to say what contribution, if 
any, anesthesia has made to these findings, 
since immunosuppressive agents, especially 
azathioprine, instituted just prior to opera-
tion, have known hepatotoxic effects. One 
patient died of acute yellow atrophy follow-
ing renal transplant, but it is probable that 
in this case azathioprine, rather than any 
anesthetic agent, was primarily responsible 
(fig. 2). 
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The Question of Methoxyflurane Anes-
thesia. - Crandell and coworkers19 ,20 ob-
served nephrotoxicity from methoxyflurane 
and recommended that this agent not be 
used in patients with renal disease. These 
reports prompted us to investigate the fate 
of 23 kidney recipients operated upon from 
a few weeks to 5 years ago. All 23 patients 
obtained good homograft function and 19 
of them are still alive. 
Other Complications.-In 6 patients, alo-
pecia appeared, after operation, in the area 
covered by the straps of the rubber head 
harness. 
Sudden onset of respiratory wheezing was 
audible during the anesthetic procedure in 
4 cases. Two episodes of what was diagnosed 
as bronchospasm subsided spontaneously, 
whereas 2 others required administration of 
aminophyllin. 
DISCUSSION 
During the 8 years of existence of the 
renal transplantation program at the Uni-
versity of Colorado, a wide range of anes-
thetic technics and agents have been em-
ployed by many different members of the 
faculty and resident staff. As a consequence, 
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FIG. 2. Course of a 26·year-old man who had the first kidney homograft implanted with obvious im-
provement of creatinine clearance. For immunosuppression, he received azathioprine and prednisone. :Five 
month later. he developed low-grade jaundice and slight elevation of transaminase. The azathioprine dose 
also reduced but the homograft eventually failed 2 years after implantation. For reimplantation, four 
large doses of azathioprine were given before and after operation, with subsequent and immediate rise of 
transaminases and serum bilirubin. He died shortly thereafter of hepatic and renal failure. The main an-
esthetic agent in both operations was fluroxene. This complication was subjective evidence of azathioprine 
hepatotoxicity. (By permission of the author, T. E. Starzl, and the publisher, W. B. Saunders Company.) 
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some practices were followed which are no 
longer considered acceptable. 
An example is the use of gallamine tri-
ethiodide, a muscle relaxant eliminated al-
most exclusively by the kidneyK~l Albeit 
prompt function of the new kidney followed 
transplant in the few patients given this 
drug, prolonged paralysis was observed in 
20 percent of them. In contrast, protracted 
paralysis was a problem in only 3.6 percent 
of patients given d-tubocurarine, which has 
both renal and hepatic pathways of detoxi-
fication and excretion.22.2:! (See adden-
dum.) 
Although succinylcholine is hydrolyzed by 
pseudocholinesterase of hepatic origin,24 its 
repeated administration may result in pro-
longed muscle paralysis (dual block) ;:.'5.:.'<1 
however, Sarmina's groupl:.' used succinyl-
choline infusion in renal recipients without 
apparent complications. Whether this com-
plication is more likely in such patients has 
not been determined; in our experience, we 
have observed it in 2 anephric patients dur-
ing thoracic surgery. 
One more unsettled aspect of the use of 
succinylcholine in this type of patient has 
been raised by isolated case reports14 ,:!7 of 
very low levels of plasma cholinesterase in 
patients who developed cardiac arrest after 
intravenous injection of the relaxant. This 
was thought to be related to the loss or 
breakdown of the enzyme during hemodi-
alysis. However, Desmond and Gordon28 
and Thomas and Holmes2D found that in-
consistent changes of serum cholinesterase 
values were produced by dialysis. A possi-
ble explanation might be a concomitant de-
gree of unnoticed hepatic insufficiency 
which produced decreased cholinesterase 
levels. Further clinical observations will be 
necessary to ascertain whether renal recipi-
ents tend to develop hypopseudocholines-
terasemia or whether some therapeutic 
agents given in th~se cases might also have 
anticholinesterase action. 
In the beginning phases of our program, 
conduction anesthesia was thought to offer 
a special advantage. However, for reasons 
that may have been as much psychologic as 
pharmacologic, it was almost alway neces-
sary to add general anesthesia during the 
course of operation. Consequently, epidural 
and subarachnoid anesthesia have not been 
used recently. Instead, inhalation anesthe-
sia combined with muscle relaxants is now 
almost always employed after induction 
with ultrashort-acting barbiturates. 
As was first emphasized by Virtue,2 the 
choice of inhalation anesthetic in renal 
transplant recipients is probably not usu-
ally critical, provided there is thorough fa-
miliarity with the potential side-effects of 
the agent. However, it may be that any 
agents in which there is a suspicion of hepa-
totoxicity should be avoided. In our series, 
halothane was the most commonly used in-
halation agent. A number of the patients 
who received this anesthetic had liver func-
tion abnormalities after kidney transplant, 
and 1 died from acute yellow atrophy. The 
tendency was to ascribe these postoperative 
findings to one or other of the immunosup-
pressive drugs, but the anesthetic may have 
been a contributory factor. 
It has already been made clear that one 
of the specific risks associated with renal 
homotransplantation is the use of anesthetic 
agents whose excretion is primarily through 
the kidney. However, the use of such agents 
is considerably less dangerous for the actual 
homograft procedure than for other opera-
tions performed in the essentially anephric 
state, such as thymectomy, nephrectomy, 
splenectomy, the insertion of dialysis 
shunts, and procedures for the control of 
pre-existing peptic ulcer disease or other 
intra-abdominal pathology. If any of the 
foregoing ancillary procedures are carried 
out before, and independent of, transplanta-
tion, the factor of renal failure is present 
throughout. In contrast, renal transplant 
almost always culminates in prompt relief 
of uremia. Despite this, it is best to ap-
proach the actual transplantation with the 
assumption that there will not necessarily 
be prompt urine excretion and that the azo-
temia may in fact not be relieved at all. If 
this attitude is taken, it should also serve 
as a stimulus to more complete preoperative 
preparation of such patients. 
The need for excellent conditions of body 
fluids and electrolytes hardly needs stating, 
since alterations of the blood biochemical 
indexes are the rule in patients with long-
standing renal failure. High blood urea and 
creatinine levels are consistently present. 
The most frequent aberrations are hyper-
kalemia, hypermagnesemia, hypercalcemia, 
and hypernatremia. Elevated serum potas-
sium concentrations do not necessarily rep-
resent high intracellular values;30 neverthe-
less, they may produce definite electrocar-
diographic alterations and either be exacer-
bated by the administration of succinylcho-
line or sensitize the digitalized heart. 
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A recently conducted study31 of 12 pa-
tients undergoing bilateral nephrectomy, 
splenectomy, and renal transplant in the 
same session showed that patients with high 
predialysis potassium levels (>6 mEq./L.) 
tended to develop hyperkalemia and elec-
trocardiographic changes, even though the 
postdialysis potassium determinations had 
been within normal limits. Consistently, 
plasma potassium values fell after revascu-
larization of the homograft. This finding 
further supports other authors' observa-
tions;4.Q,10,13 as a whole, it is concluded 
that continuous electrocardiographic sur-
veillance is in order in anesthetized patients 
with renal failure. Serial plasma potassium 
determinations are also recommended if 
predialysis values exceeded 6 mEq./L. 
The incidence and onset of arterial hypo-
tension deserves further comment. Although 
analyzed by the usual criterion, blood pres-
sure falls of 25 percent of the preanesthetic 
value, hypotension may have been more 
relative than absolute in these patients. Hy-
pertension was a common preoperative find-
ing; it is, therefore, not surprising that 
after induction of general anesthesia in an 
appr~~e~siveI underpremedicated patient, 
the mltIally elevated reading decreased to 
a more normal level. The frequency of this 
event during the 1st hour of anesthesia fur-
t~er sll:bstantiates this premise. Hypoten-
SlVe epIsodes below levels that might have 
compromised perfusion of vital organs were 
rare. 
The immediate lowering of blood pres-
s~re is probably due to a moderate depres-
SlVe effect of the anesthetic agents upon the 
cardiovascular system with little or no medi-
ation of the renal humoral mechanism. This 
contention is based on observations made 
during our clinical experience, since it has 
repeatedly been noted that when a uremic 
patient is made anatomically anephric, the 
blood pressure returns nearly to its pre-
operative high levels, only to trend fre-
quently toward normality after successful 
renal transplant. This latter phenomenon 
has also been noticed in other patients after 
homograft function, even when both di-
seased kidneys have been left in situ. 
Uremic patients usually have low hema-
tocrit value~I representing a normocytic, 
norm<><;hromlc anemia, varying in degree 
accordmg to the severity and duration of 
renal failure. This is basically due to two 
factors, decreased erythropoiesis and hemol-
ysis. The effect on erythropoiesis is related 
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to the decrease in renal mass and hence de-
creased ability to respond to a drop in red 
blood cell mass with increased erythropoi-
etin production.32 This in turn is reflected 
in bone marrow hypoplasia and decreased 
iron utilization, which occur in uremia. 
Satisfactory chronic hemodialysis is as-
sociated with a gradual but slowly progres-
sive improvement in hematopoiesis.33 Red 
blood cell survival as measured with 51Cr 
varies inversely with the level of azotemia. 
In some patients with acute renal insuf-
ficiency, there may be a predominance of 
hemolysis. However, in more chronic cases 
of renal failure, there is impaired erythro-
poiesis. Consequently, anemia develops 
gradually with a compensatory expansion 
of plasma volume. Attempts to bring the 
hematocrit to normal levels by rapid trans-
fusions may be not only futile but even 
dangerous. 
In this series, preoperative hematocrit 
values ranged from 15 to 38 percent, with 
an average of 24 percent. Under other cir-
cumstances, these low values might have 
been una~ceptable; however, in our experi-
ence and m that of others,34,35 patients with 
chronic anemia tolerate anesthesia remark-
ably well, probably because they have a 
normal or higher than normal plasma vol-
ume.36 It is, therefore, recommended not to 
set a specific rule as to an acceptable he-
matocrit but rather to evaluate each patient 
individually. 
q~eK arrival. o.f a renal homograft in pre-
sensltlzed reclpzents may carry certain other 
dangers ~o life that have yet to be fully 
characterIzed. In 1 of our patients37 in 
whom preformed antigraft antibodies were 
pre~entI there was joint effusion, hyperpy-
rexia,. and rapid cessation of homograft 
fr~lCtllnK Intraoperative febrile states may 
~nse .from a number of causes, including 
l~fe<:tf~nI the use of antilymphocyte globu-
~lnIl"KlD and blood transfusions. However, 
If sudden fevers are observed shortly after 
revascularization, the possibility of an im-
mediate immunologic reaction involving the 
homograft must be strongly considered. In 
s~ch an event, acute aberrations in coagula-
hon may follow and may require joint man-
agement by the anesthesiologists and an ex-
pert in coagulation disorders.38 
SUMMARY 
In the anesthetic management of 260 
cases .of renal transplant, most recipients 
were m the young but poor-risk category. 
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The choice of anesthetic agent was partly 
determined by the realization that the pre-
existing anephric state might not be prompt-
ly relieved. Violation of this general rule, 
as with the administration of the muscle 
relaxant, gallamine, was followed by an in-
creased incidence of pharmacologic compli-
cations. Conduction anesthesia was gener-
ally found unsuitable for renal transplant, 
since supplementary general anesthesia was 
too often required. 
The anesthesia-related intraoperative and 
postoperative complications in this series 
included hypotension, cardiac arrhythmias 
(with two cardiac arrests), temperature 
changes, failure of anesthetic detoxification, 
and hyperpyrexia. The reasons for many of 
these complications as well as precautions 
to prevent them in future cases are dis-
cussed. 
Addendum. A recent report (Anesth. & 
Analg. 50:11-16, 1971) demonstrated that 
anephric patients may receive gallamine as 
long as the dose is curtailed. 
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Generic and Trade Names of Drugs 
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Tubocurarine 
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